University Spinout Branding
The paper was peer reviewed. The company has not been.
Branding, naming and websites for companies spinning out of a university or national lab. The science already has credibility. The company has none yet, and the two are not transferable.
In short
Answer summary- Who is it for?
- Companies spinning out of a university or national lab, before go-to-market.
- What goes wrong?
- The lab's credibility does not transfer to the company, and the page is written as a paper.
- What do you get?
- Separation naming, positioning, narrative, identity, website and investor deck.
- When is the right time?
- Once the licence terms are settled and before go-to-market.
A publication proves the research. It does not prove a company.
Four problems specific to a company that started inside an institution.
- →The credibility does not transfer. The lab has thirty years of reputation and the spinout has a logo made in a presentation tool. Buyers and investors read the second one, not the first.
- →The name belongs to someone else. Working titles built from the lab, the grant or the principal investigator rarely survive separation, and the institution usually has a view on which parts of the name it is willing to let go.
- →The page is written as a paper. Abstract, method, results. Accurate, peer-reviewable and unreadable by anyone deciding whether to buy or fund it. The order that convinces a reviewer is not the order that convinces a buyer.
- →The licence is the business model. What is licensed, what is exclusive and what the institution retains is often the most commercially important fact about the company, and it is usually missing from the site entirely.
Six deliverables, one price.
A company name that is defensibly yours rather than the lab's, screened before anyone commits.
The category the company is entering, which is rarely the field the research was published in.
The research restated in the order a buyer decides, without losing what makes it true.
A mark and system that reads as a company rather than a project under an institution.
Including the licensing and IP position, stated plainly.
The version that travels to a fund rather than a grant committee.
Where this has already run.
The e200X, a compact electric air taxi incubated at IIT Madras. The first application is an air ambulance.
The argument, at length.
Questions we get about this.
How early should we do this?
Once the licence terms are settled and before go-to-market. Branding a spinout whose IP position is still being negotiated means redoing it when the terms land.
Can you work with the institution's tech transfer office?
Yes, and it is usually necessary. What the company may claim about the research is a licensing question before it is a marketing one.
Does the founder stay academic in tone?
The register shifts and the rigour does not. The claims still have to survive a reviewer; they just arrive in the order a buyer reads.
What if we cannot use the lab's name?
Common, and usually better. A name of your own is an asset the company owns rather than borrows, and the association can still be stated in words.
Do you sign an NDA first?
Yes. Unpublished results and unfiled IP are the normal starting condition.
The rest of the stack.
Send us the deck and the spec sheet.
Thirty minutes, no deck from us. We will tell you which category you are being read into and what we would change first.
Book a 30-minute audit →(opens in a new tab)